Brief: Nexalin Technology Announces Regulatory Approval In Oman For Gen-2 Neurostimulation Device
Feb 8 (Reuters) - Nexalin Technology Inc NXL.O :
* NEXALIN TECHNOLOGY ANNOUNCES REGULATORY APPROVAL IN OMAN
FOR
GEN-2 NEUROSTIMULATION DEVICE
* NEXALIN TECHNOLOGY - GEN-2, 15 MILLIAMP (MA)
NEUROSTIMULATION
DEVICE, HAS BEEN GRANTED REGULATORY APPROVAL BY SULTANATE OF
OMAN'S MINISTRY OF HEALTH
Source text for Eikon: ID:nGNXcg9J0d
Further company coverage: NXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexalin Technology
See all newsBrief: Nexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement Nasdaq Hearings Panel Grants Request For Continued Listing
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 10:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM